| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/14/2023 | 139.23% | Stifel | $9 → $5 | Maintains | Buy |
| 07/21/2023 | 187.08% | Stephens & Co. | → $6 | Reiterates | Overweight → Overweight |
| 05/09/2023 | 330.62% | Benchmark | $15 → $9 | Maintains | Buy |
| 05/09/2023 | — | HC Wainwright & Co. | Downgrades | Buy → Neutral | |
| 04/17/2023 | 569.86% | Piper Sandler | $21 → $14 | Maintains | Overweight |
| 02/27/2023 | 330.62% | HC Wainwright & Co. | $15 → $9 | Maintains | Buy |
| 01/19/2023 | 1000.48% | Piper Sandler | $22 → $23 | Maintains | Overweight |
| 11/07/2022 | 617.7% | HC Wainwright & Co. | $25 → $15 | Maintains | Buy |
| 08/08/2022 | 1096.17% | HC Wainwright & Co. | $27 → $25 | Maintains | Buy |
| 07/18/2022 | 1191.87% | HC Wainwright & Co. | $38 → $27 | Maintains | Buy |
| 07/15/2022 | 904.78% | Cowen & Co. | $39 → $21 | Maintains | Outperform |
| 07/15/2022 | 952.63% | Piper Sandler | $35 → $22 | Maintains | Overweight |
| 05/11/2022 | 952.63% | Stephens & Co. | $26 → $22 | Maintains | Overweight |
| 11/05/2021 | 1718.18% | HC Wainwright & Co. | $33 → $38 | Maintains | Buy |
| 10/15/2021 | 1478.95% | HC Wainwright & Co. | $28 → $33 | Maintains | Buy |
| 08/06/2021 | 1239.71% | HC Wainwright & Co. | $27 → $28 | Maintains | Buy |
| 06/18/2021 | 1191.87% | HC Wainwright & Co. | $26 → $27 | Maintains | Buy |
| 04/12/2021 | 1431.1% | Piper Sandler | → $32 | Initiates Coverage On | → Overweight |
| 03/01/2021 | 1335.41% | Stifel | → $30 | Initiates Coverage On | → Buy |
| 02/26/2021 | 1144.02% | HC Wainwright & Co. | $21 → $26 | Maintains | Buy |
| 05/11/2020 | 904.78% | HC Wainwright & Co. | $22.5 → $21 | Reiterates | → Buy |
| 01/17/2019 | — | First Analysis | Upgrades | Neutral → Outperform |
What is the target price for Codexis (CDXS)?
The latest price target for Codexis (NASDAQ: CDXS) was reported by Stifel on August 14, 2023. The analyst firm set a price target for $5.00 expecting CDXS to rise to within 12 months (a possible 139.23% upside). 8 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Codexis (CDXS)?
The latest analyst rating for Codexis (NASDAQ: CDXS) was provided by Stifel, and Codexis maintained their buy rating.
When is the next analyst rating going to be posted or updated for Codexis (CDXS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Codexis, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Codexis was filed on August 14, 2023 so you should expect the next rating to be made available sometime around August 14, 2024.
Is the Analyst Rating Codexis (CDXS) correct?
While ratings are subjective and will change, the latest Codexis (CDXS) rating was a maintained with a price target of $9.00 to $5.00. The current price Codexis (CDXS) is trading at is $2.09, which is out of the analyst's predicted range.